𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival

✍ Scribed by A Jain; R Pokharna; B Eghtesad; S Potdar; R Kashyap; L Kingery; J Fung

Book ID
117232272
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
90 KB
Volume
34
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Recurrence of autoimmune disease, primar
Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation
✍ Jean-Charles Duclos-Vallee; MylΓ¨ne Sebagh πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 424 KB πŸ‘ 1 views

1. Recurrence of primary sclerosing cholangitis. a Five percent of liver transplants are performed because of end-stage liver disease secondary to primary sclerosing cholangitis. b Recurrent disease affects 10% to 27% of recipients. c Diagnostic criteria of recurrence include the following: A confir

Long-term survival and impact of ursodeo
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation
✍ Phunchai Charatcharoenwitthaya; Sylvania Pimentel; Jayant A. Talwalkar; Felicity πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 275 KB πŸ‘ 2 views

The recurrence of primary biliary cirrhosis (PBC) in the hepatic allograft may impact patient and graft survival with long-term follow-up. The efficacy of ursodeoxycholic acid (UDCA) for treatment of recurrent PBC after liver transplantation (LT) remains less well known. The aims of this study were